As of Sep 01
| -0.70 / -3.50%|
The 8 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 28.50, with a high estimate of 34.00 and a low estimate of 24.00. The median estimate represents a +47.82% increase from the last price of 19.28.
The current consensus among 10 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.